Re: Late-onset neutropenia with clozapine [1]

Canadian Journal of Psychiatry

Volumn 51, Issue 2, 2006, Pages 125-

  Duggal, Harpreet S ^a   Singh, Ira ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; VALPROIC ACID;

AGRANULOCYTOSIS; DETERIORATION; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; LETTER; LEUKOCYTE COUNT; NEUTROPENIA; NEUTROPHIL COUNT; TREATMENT WITHDRAWAL;

EID: 33644546363     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370605100213     Document Type: Letter

References (7)

1. Thompson A, Girishchandra B, Castle D, Orr K. Late-onset neutropenia with clozapine. Can J Psychiatry 2004;49:647-8.
2. Palmblad J, Papadaki HA, Eliopoulos L. Acute and chronic neutropenia. What is new? J Intern Med 2001;250:476-91.
3. Watts RG, Emanuel PD, Zuckerman KS, Howard TH. Valproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis. J Pediatr 1990;117:495-9.
4. Pantelis C. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine. Aust N Z J Psychiatry 2001;35:544-5.
5. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry 1999;175:576-80.
6. Ahn YM, Jeong SH, Jang HS, Koo YJ,Kang, UG, Lee KY, and others. Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results. Int Clin Psychopharmacol 2004;19:97-101.
7. Senechal A, Landry P, Deschamps R, Lessard M. Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs. Encephale 2002;28:567-9.